webinar - surviving sepsis: state of the art
DESCRIPTION
Intervention: Sepsis Date: Thursday, May 8, 2014 Sponsor: •Canadian Patient Safety Institute •Canadian ICU Collaborative Speakers: •John C. Marshall, MD FACS, St. Michael’s Hospital, University of Toronto Purpose of the Call: Provide update on the Surviving Sepsis CampaignTRANSCRIPT
SURVIVING SEPSIS: STATE OF THE ART
Thursday, May 8 2014 Jeudi 8 mai 2014
Your Hosts & Presenters Vos hôtes et présentateurs
Bruce Harries, Moderator
Denny Laporta, MD, FRCPC, CSPQ
Ardis Eliason, Technical Host
John C. Marshall, MD, FRCSC, FACS
2 08/05/2014
Interacting in WebEx: Today’s Tools Interagir dans Webex : outils à utiliser
3
Be prepared to use: - Pointer - Raise hand - CHAT - Text Tool “writing on the slide” - Shape Tools
Have you used WebEx before? Avez-vous déjà utilisé WebEx? YES / OUI NO / NON
Soyez prêts à utiliser les outils : - le pointeur - lever la main - clavardage - Outil textuel pour « écrire sur la diapo » - Outils de forme
08/05/2014
Type your message & click ‘send’
Select ‘send to’
4
Who’s Online? Qui est en ligne?
POINTER
08/05/2014
What professions are represented? Quelles professions sont représentées?
Nurse MD
Educator / Quality Improvement Professional
Infection Control
Administrator / Senior Leader
Other
POINTER
Respiratory Therapist
Nutritionist
5 08/05/2014
Dr. John C. Marshall
Surviving Sepsis: State of the Art
The Surviving Sepsis Campaign:
State of the Art
St. Michael’s Hospital University of Toronto
John C. Marshall MD FACS
Safer Healthcare Now May 8, 2014
Paris, 1997 …
• Definitions • Diagnosis of infection • Antibiotics • Hemodynamic support • Source control • ICU care • Adjunctive therapies • Novel therapies
Phase 1 Barcelona declaration Phase 2 Evidence-based guidelines Phase 3 Implementation and evaluation
A global program to reduce mortality rates in severe sepsis
ESICM, ISF and SCCM
Partially funded by unrestricted educational grants
from Baxter, Edwards, Philips and Lilly
Sponsoring Organizations • American Association of Critical Care Nurses • American College of Chest Physicians • American College of Emergency Physicians • American Thoracic Society • Australian and New Zealand Intensive Care Society • European Society of Clinical Microbiology and Infectious
Diseases • European Society of Intensive Care Medicine • European Respiratory Society • International Sepsis Forum • Society of Critical Care Medicine • Surgical Infection Society
Guidelines Meeting
London, England
June 2003
- Crit Care Med 32:858, 2004
The Sepsis Bundles
• Institute for Healthcare Improvement (IHI)
• Measurable activities that indicate compliance with guidelines
- N Engl J Med 355:1640, 2006
San Francisco, January 2006
American Association of Critical-Care Nurses American College of Chest Physicians American College of Emergency Physicians American Thoracic Society Canadian Critical Care Society European Society of Clinical Microbiology and Infectious Diseases European Society of Intensive Care Medicine European Respiratory Society International Sepsis Forum Society of Critical Care Medicine Japanese Association for Acute Medicine Japanese Society of Intensive Care Medicine Surgical Infection Society Participation and endorsement by the German Sepsis Society and the Latin American Sepsis Institute.
Sponsors 2006
- Crit Care Med 36:296, 2008
Miami 2010
- Crit Care Med 41:580, 2013
Grading of Recommendations
Assessment, Development, and Evaluation
• Strength of the Evidence
• Strength of the Recommendation
Improving Sepsis Care
• Recognition
• Resuscitation
• Diagnosis and treatment of infection
• Physiologic support
Improving Sepsis Care
• Recognition
• Resuscitation
• Diagnosis and treatment of infection
• Physiologic support
Rates of Sepsis, U.S. 1979 - 2001
- Martin, N Engl J Med 348:1546, 2003
Sepsis in the Emergency Department
• Acute change in health status
• Unexplained organ dysfunction
• Febrile illness
• Underlying co-morbidities
Sepsis on the
Hospital Ward
• Fever, tachycardia
• Altered mental status
• Fluid retention
• New organ dysfunction
• Often subtle presentation
Sepsis
Think of it!
Improving Sepsis Care
• Recognition
• Resuscitation
• Diagnosis and treatment of infection
• Physiologic support
Optimize Oxygen Delivery to Tissues
• Restore intravascular volume
• Support cardiac function
• Provide oxygen
• Enhance O2 carrying capacity
Lactate Metabolism
Anerobic
Aerobic
Resuscitation
Early Goal-directed Therapy for Septic Shock
Standard Goal-Directed (N=133) (N=130) MVO2 65.3+11.4 70.4+10.7* APACHE II 15.9+6.4 13.0+6.3* Mortality 46.5% 30.5%*
* p<0.02 - Rivers, N Engl J Med 345:1368, 2001
CVP
Mean Arterial Pressure > 8
<8 Fluids
ScvO2
> 65 <65
Pressors
Goals achieved > 70 Transfusion,
Inotropes
- Angus, N Engl J Med 370:1683, 2014
The SAFE Study Investigators, N Engl J Med 2004;350:2247
Saline and Albumin are Equally Efficacious
Mortality is Increased with Starches
- Zarychanski, JAMA 309:678, 2013
- N Engl J Med 370:1583, 2014
- N Engl J Med 370:1583, 2014
Improving Sepsis Care
• Recognition
• Resuscitation
• Diagnosis and treatment of infection
• Physiologic support
Diagnosis
Antibiotics
Source Control
Odd
s R
atio
for D
eath
(9
5% C
I)
1
10
100
Time from Onset of Hypotension (Hours)
-Kumar, Crit Care Med 34:1589, 2006
Impact of Delayed Antibiotic Therapy on Clinical Outcome
“Early versus late necrosectomy in severe necrotizing pancreatitis”
Number Mortality Early 25 58% Late 11 27%
- Mier et al Am.J.Surg 173:71, 1997
Improving Sepsis Care
• Recognition
• Resuscitation
• Diagnosis and treatment of infection
• Physiologic support
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury
and the acute respiratory distress syndrome
Mortality (%) Controls 39.8
Volume-limited 31.0*
ARDSNet; NEJM 342:1301, 2000
*P=0.007
Impact of Fluid Strategy in ARDS
Conservative Liberal p. (N=503) (N=497) 60 day mortality 25.5% 28.4% 0.30 Ventilator-free days 14.6±0.5 12.1±0.5 <0.001 ICU-free days 13.4±0.4 11.2±0.4 <0.001 CNS failure FD 18.8±0.5 17.2±0.5 0.03
- ARDSNet, N Engl J Med 354:2564, 2006
Survival in NICE/SUGAR
Drotrecogin alfa was ineffective in low risk patients …
Abraham E N Engl J Med 2005;353:1332
Time to Shock Reversal
Survival Sprung et al, N Engl J
Med 358:111,2008
CORTICUS
N=499
Has It Made a Difference?
• Global process change initiative based on “sepsis bundles”
• 15,022 patients enrolled
• 7% absolute, 5.4% relative mortality reduction (p<0.001)
Surviving Sepsis Campaign
Unadjusted Risk-adjusted
Bundle target Population N OR p-value
OR 95% CI p-value
Measure Lactate All 15,022 0.86 <0.0001
0.97 [0.90, 1.05] 0.48
Obtain blood cultures before antibiotics All 15,022
0.70 <0.0001 0.76 [0.70, 0.83] <0.0001
Commence broad-spectrum antibiotics All 15,022
0.78 <0.0001 0.86 [0.79, 0.93] <0.0001
Achieve tight glucose control All 15,022 0.65 <0.0001
0.67 [0.62, 0.71] <0.0001
Administer drotrecogin alfa Multi-organ failure 8,733 0.90 0.26
0.84 [0.69, 1.02] 0.07
Administer drotrecogin alfa Shock despite fluids 7,854 0.91 0.30
0.81 [0.68, 0.96] 0.02
Administer low-dose steroids Shock despite fluids 7,854 1.06 0.18
1.06 [0.96, 1.17] 0.24
Demonstrate CVP ≥ 8 mm Hg Shock despite fluids 7,854 1.08 0.10
1.00 [0.89, 1.12] 0.98
Demonstrate ScvO2 ≥ 70% Shock despite fluids 7,854 0.94 0.24
0.98 [0.86, 1.10] 0.69
Achieve low plateau pressure control Mechanical ventilation 7,860 0.67 <0.0001
0.70 [0.62, 0.78] <0.0001
- Kaukonen et al JAMA 2014
Survival in Sepsis is Improving
Conclusions • The SSC has raised awareness regarding sepsis management and defined optimal approaches to care
• This has been associated with improved survival
• But the elements responsible for that improvement need further study
Thank You!!
QUESTIONS?
RAISE YOUR HAND / LEVEZ LA MAIN
OR/OU
CHAT TO “ALL PARTICIPANTS”
62
a Canadian Critical Care Knowledge Translation Network
“aC3KTion Net”
63
aC3KTion Net • Network of ICUs (Networks) from across
Canada • Academic • Community
• Primary activity will be Knowledge Translation and development of Critical Care Knowledge Synthesis products
• Not KT Research
• Measurement of uptake/outcomes
64
Network Activities • Measurement of current practice • Knowledge Synthesis: Development of clinical practice guidelines,
evidence syntheses and scoping reviews.
• Testing of Knowledge Products: Reviewed and tested before implementation, to ensure acceptability, ability to achieve intended purpose and ascertain possible barriers
• Knowledge Implementation: Local teams will use strategies/tools tailored to knowledge product. – Education, protocols, checklists, order sets, organizational changes and
reminder systems – PDSA cycles to track implementation activities
65
Even when motivated to change our behavior, we cannot manage what we do not measure.
Measurement can identify gaps in best practice.
Measurement can illuminate the results of our efforts at implementing best practice.
Measurement can inform future research direction.
Measurement- Why?
Model for Participation • Main benefits of participation
– Access to KT activities/initiatives – Access to KS products – Access to educational events/webinars – Access to a repository of knowledge products, protocols etc. – Opportunity to participate in incubator units – Ability to influence network activities – Benchmarked reports of performance with national peers – A vehicle to drive critical care quality improvement
• ICUs provide periodic data in return
66
Current Status
• Baseline Data Collection – Started and ongoing. Site recruitment ongoing.
• Development of barriers/enablers Questionnaires – Completed
• Repository of KT tools/Products – Being populated
• KT activities – Slated for 2014
67
68
Questions/Comments?
Canadian ICU Collaborative Faculty
Paule Bernier, P.Dt., Msc, Présidente, Ordre professionnel des diététistes du Québec; Sir MB David Jewish General Hospital (McGill University), Montreal
Paul Boiteau MD, Department Head, Critical Care Medicine, Alberta Health Services; Professor of Medicine, University of Calgary Mike Cass, BSc, RN, MScN, Advanced Practice Nurse, Trillium Health Centre Leanne Couves, Improvement Advisor, Improvement Associates Ltd. Maryanne D’Arpino, Patient Safety Improvement Lead, CPSI Bruce Harries, Collaborative Director, Improvement Associates Ltd. Denny Laporta MD, Intensivist, Department of Adult Critical Care, Jewish General Hospital; Faculty of Medicine, McGill University Claudio Martin MD,Intensivist, London Health Sciences Centre, Critical Care Trauma Centre; Professor of Medicine and Physiology,
University of Western Ontario; Chair/Chief of Critical Care Western Cathy Mawdsley, RN, MScN, CNCC; Clinical Nurse Specialist – Critical Care, London Health Sciences Centre; John Muscedere MD, Assistant Professor of Medicine, Queens University; Intensivist, Kingston General Hospital Yoanna Skrobik MD, Intensivist, Hôpital Maisonneuve Rosemont, Montréal; Expert Panel for the new Pain, Sedation and Delirium
Guidelines, Society of Critical Care Medline (SCCM)
69 08/05/2014
Reminders Rappels
Call is recorded Slides and links to
recordings will be available on Safer Healthcare Now! Communities of Practice
Additional resources are available on the SHN Website and Communities of Practice
L'appel est enregistré Les diapositives et liens
vers les enregistrements seront disponibles sur Des soins de santé plus sécuritaires maintenant! Communautés de pratique
Des ressources supplémentaires sont disponibles sur le site Web SSPSM et Communautés de Pratique
70 08/05/2014
THANK YOU MERCI
This National Call is hosted by:
Supported by:
72 08/05/2014